Pharmacovigilance (PV) plays a key role in Clinical Research through assessment, monitoring and discovery of interactions amongst drugs and their effects on humans. Pharmaceutical and Biotechnological medicines are designed to cure, prevent or treat diseases; However, there are risks particularly Adverse Drug Reactions (ADRs) which can cause serious harm to patients. Thus, ADR monitoring is required for each medicine throughout its life cycle. Especially, during early stages of drug design, development, clinical trials, pre-marketing, and post-marketing surveillance. PV is concerned with the detection, assessment, understanding and prevention of ADRs